NO970582L - Fremgangsmåte og blandinger nyttige i profylakse og behandling av endotoksin-relaterte tilstander - Google Patents

Fremgangsmåte og blandinger nyttige i profylakse og behandling av endotoksin-relaterte tilstander

Info

Publication number
NO970582L
NO970582L NO970582A NO970582A NO970582L NO 970582 L NO970582 L NO 970582L NO 970582 A NO970582 A NO 970582A NO 970582 A NO970582 A NO 970582A NO 970582 L NO970582 L NO 970582L
Authority
NO
Norway
Prior art keywords
endotoxin
prophylaxis
treatment
methods
compositions useful
Prior art date
Application number
NO970582A
Other languages
English (en)
Other versions
NO970582D0 (no
NO313786B1 (no
Inventor
Daniel M Levine
Thomas S Parker
Albert L Rubin
Bruce R Gordon
Stuart D Saal
Original Assignee
Rogosin Inst The
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26965092&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO970582(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/288,568 external-priority patent/US5506218A/en
Application filed by Rogosin Inst The filed Critical Rogosin Inst The
Publication of NO970582D0 publication Critical patent/NO970582D0/no
Publication of NO970582L publication Critical patent/NO970582L/no
Publication of NO313786B1 publication Critical patent/NO313786B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19970582A 1994-08-10 1997-02-07 Proteinfrie og peptidfrie farmasöytiske blandinger, samt anvendelse derav for fremstilling av medikamenter NO313786B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/288,568 US5506218A (en) 1992-08-12 1994-08-10 Methods useful in endotoxin based therapy
US08/487,459 US5674855A (en) 1992-08-12 1995-06-07 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
PCT/US1995/010189 WO1996004916A1 (en) 1994-08-10 1995-08-10 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions

Publications (3)

Publication Number Publication Date
NO970582D0 NO970582D0 (no) 1997-02-07
NO970582L true NO970582L (no) 1997-04-07
NO313786B1 NO313786B1 (no) 2002-12-02

Family

ID=26965092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970582A NO313786B1 (no) 1994-08-10 1997-02-07 Proteinfrie og peptidfrie farmasöytiske blandinger, samt anvendelse derav for fremstilling av medikamenter

Country Status (27)

Country Link
US (1) US5674855A (no)
EP (1) EP0767666B1 (no)
JP (1) JP3818660B2 (no)
CN (1) CN1137688C (no)
AP (1) AP782A (no)
AT (1) ATE255415T1 (no)
AU (1) AU703861C (no)
BG (1) BG61967B1 (no)
BR (1) BR9508584A (no)
CA (1) CA2196906C (no)
CY (1) CY2514B1 (no)
CZ (1) CZ287614B6 (no)
DE (1) DE69532239T2 (no)
DK (1) DK0767666T3 (no)
ES (1) ES2211915T3 (no)
FI (1) FI118035B (no)
HK (1) HK1003709A1 (no)
HU (1) HUT77605A (no)
NO (1) NO313786B1 (no)
NZ (1) NZ292315A (no)
OA (2) OA11737A (no)
PL (1) PL182043B1 (no)
PT (1) PT767666E (no)
RO (1) RO115782B1 (no)
RU (1) RU2174839C2 (no)
SK (1) SK282493B6 (no)
WO (1) WO1996004916A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518412B1 (en) 1997-09-29 2003-02-11 Jean-Louis Dasseux Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6037323A (en) * 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6046166A (en) * 1997-09-29 2000-04-04 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
DK1158989T3 (da) * 1999-03-09 2007-10-22 Anker Stefan Anvendelse af inhibitorer af endotoksin til behandling af kakeksi
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
CA2486127C (en) 2002-05-17 2014-03-11 Esperion Therapeutics, Inc. Method of treating dyslipidemic disorders
ATE358992T1 (de) * 2003-02-05 2007-05-15 Nutricia Nv Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ES2372499T3 (es) * 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
AU2006284990B2 (en) * 2005-08-29 2011-01-06 Sepsicure L.L.C. Method for treatment or prevention of conditions caused by gram-positive bacteria
GB0522942D0 (en) 2005-11-10 2005-12-21 Leigh Steven Dissolution composition
US8163699B2 (en) 2006-06-01 2012-04-24 Montreal Heart Institute Method for the treatment of valvular disease
KR100785656B1 (ko) * 2007-05-14 2007-12-17 재단법인서울대학교산학협력재단 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체
RU2532222C2 (ru) 2009-02-16 2014-10-27 Серенис Терапьютикс Холдинг С.А, Миметики аполипопротеина а-i
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2675460A4 (en) 2011-02-18 2014-07-09 Kythera Biopharmaceuticals Inc TREATMENT OF FAT TISSUE UNDER CHIN
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US9023833B2 (en) * 2012-12-18 2015-05-05 Sepsicure, LLC Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
DE2556592C2 (de) * 1975-12-16 1986-10-09 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittelzubereitungen auf Basis öliger Lösungen von Phospholipiden
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
CA1237671A (en) * 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
JPS6193111A (ja) * 1984-05-28 1986-05-12 Funayama Seizo 発熱性物質除去方法
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
DE4017979A1 (de) * 1990-06-05 1991-12-12 Meyer Lucas Gmbh & Co Lipid- bzw. phospholipid-zusammensetzungen sowie diese enthaltendes mittel zur behandlung von erkrankungen sowie auf die zellmembrane zurueckzufuehrende stoerungen
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas

Also Published As

Publication number Publication date
ES2211915T3 (es) 2004-07-16
DE69532239T2 (de) 2004-10-21
CA2196906A1 (en) 1996-02-22
AP9700921A0 (en) 1997-01-31
SK17697A3 (en) 1997-09-10
HK1003709A1 (en) 1998-11-06
CZ37197A3 (en) 1997-10-15
PL318593A1 (en) 1997-06-23
DK0767666T3 (da) 2004-04-05
FI118035B (fi) 2007-06-15
CY2514B1 (en) 2005-12-23
HUT77605A (hu) 1998-06-29
NO970582D0 (no) 1997-02-07
AU703861B2 (en) 1999-04-01
EP0767666A4 (en) 1998-10-07
BG101288A (en) 1997-09-30
JP3818660B2 (ja) 2006-09-06
US5674855A (en) 1997-10-07
FI970534A (fi) 1997-02-07
NZ292315A (en) 1998-10-28
AU703861C (en) 2001-12-20
OA10598A (en) 2002-07-15
SK282493B6 (sk) 2002-02-05
WO1996004916A1 (en) 1996-02-22
CN1137688C (zh) 2004-02-11
ATE255415T1 (de) 2003-12-15
RU2174839C2 (ru) 2001-10-20
AP782A (en) 1999-11-15
AU3405295A (en) 1996-03-07
CA2196906C (en) 2004-03-02
EP0767666B1 (en) 2003-12-03
PT767666E (pt) 2004-04-30
OA11737A (en) 2005-05-12
JPH10504037A (ja) 1998-04-14
FI970534A0 (fi) 1997-02-07
EP0767666A1 (en) 1997-04-16
CZ287614B6 (en) 2001-01-17
NO313786B1 (no) 2002-12-02
BR9508584A (pt) 1997-10-21
PL182043B1 (pl) 2001-10-31
CN1158087A (zh) 1997-08-27
BG61967B1 (bg) 1998-11-30
RO115782B1 (ro) 2000-06-30
DE69532239D1 (de) 2004-01-15

Similar Documents

Publication Publication Date Title
NO970582L (no) Fremgangsmåte og blandinger nyttige i profylakse og behandling av endotoksin-relaterte tilstander
DE69406116D1 (de) Reinigungszusammensetzung und verwendungsverfahren
FI950587A (fi) Endotoksiinimyrkytyksen ennaltaehkäisyssä ja hoidossa käyttökelpoisia menetelmiä
GB9422571D0 (en) Haemorrihoidal compositions and method of use
HUP9901760A3 (en) Bioactive glass compositions and methods of treatment using bioactive glass
NO982311D0 (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt
EP0573581A4 (en) Compositions and methods of treatment of sympathetically maintained pain
EP0688052A3 (en) Improvements in or related to the manufacture of a semiconductor device
PL327658A1 (en) Disinfecting compositions and methods of disinfecting surfaces
EP0581581A3 (en) Bioadhesive treatment compositions and methods of use
ZA941860B (en) Halogen compositions for water treatment and method of preparation thereof
DE69406920T2 (de) Analyt-reagierende ktp zusammensetzung und verfahren
PL331006A1 (en) Risk assessing method for use in cardiovascular diseases and other diseases as well as phytosterol-based compositions useful in prophylaxis and treatment of cardiovascular and other diseases
NO965563D0 (no) Behandling og profylakse av osteoporese
PL331708A1 (en) Treatment of common cold and allergic rhinitis
NO971900D0 (no) Blandinger og behandling av multippel sklerose
DE69209118T2 (de) Entfärbungszusammensetzung und Entfärbungsverfahren
ZA915371B (en) Antitumor compositions and methods of treatment
PL327945A1 (en) Disinfecting compositions and methods of disinfecting surfaces
NO984836D0 (no) Substituerte benzylaminer og deres anvendelse for behandling av depresjon
GB9014307D0 (en) Method of treatment and compositions therefor
AU7894591A (en) Composition against ozone damages to cultivations and method for its application
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
ZA915682B (en) Method of treatment of allergic conjunctivitis
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory

Legal Events

Date Code Title Description
MK1K Patent expired